[Form 4] Primoris Services Corporation Insider Trading Activity

Rhea-AI Filing Summary

Primoris Services Corp. (PRIM) Form 4: On 07/30/2025, non-employee director Carla S. Mashinski received 499 restricted shares of PRIM common stock under the Board’s director compensation program last updated July 2024. The grant value was $37,500, calculated from the average June 2025 closing price. The shares are subject to a 12-month transfer restriction. Following the award, Mashinski’s direct beneficial ownership rises to 23,310 shares. No derivative securities were involved and no shares were sold or disposed. The filing was signed by Attorney-in-Fact Kenneth M. Dodgen.

This routine equity grant reflects standard director compensation; it does not signal insider buying or selling pressure and has no material impact on Primoris’s capital structure.

Positive

• Equity-based compensation continues to align director interests with shareholders.
• No shares were sold, avoiding negative selling signals to the market.

Negative

• Immaterial size (499 shares) provides little insight into insider sentiment.
• No financial metrics or strategic information; limited value for forecasting.

Insights

Corporate Governance Analyst

TL;DR: Routine director stock grant; aligns incentives but immaterial to valuation.

The 499-share restricted stock award, worth roughly $37.5k, is consistent with Primoris’s long-standing non-employee director pay policy. Such equity grants modestly strengthen director–shareholder alignment by tying compensation to share performance. However, the share count represents less than 0.001% of PRIM’s outstanding stock, so no ownership concentration or control shift occurs. Because the award is locked up for 12 months, immediate market liquidity is unaffected. Overall impact on governance quality is marginally positive; financial impact is negligible.

Securities Analyst

TL;DR: Neutral insider activity; no buy/sell signal for investors.

Form 4 shows an A code (acquisition) tied to compensation, not open-market purchasing. Investors should not interpret this as bullish conviction buying. With post-grant holdings at 23,310 shares, Mashinski maintains a moderate board-level stake, which is typical for companies of Primoris’s size. There are no price disclosures beyond grant-date valuation, and no derivatives or 10b5-1 sales. Consequently, the filing is not impactful to PRIM’s near-term trading dynamics or valuation models.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MASHINSKI CARLA S

(Last) (First) (Middle)

C/O PRIMORIS SERVICES CORPORATION

2300 N. FIELD STREET, SUITE 1900

(Street)

DALLAS TX 75201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Primoris Services Corp [ PRIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2025		A		499	A	(1)	23,310	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during June 2025, resulting in a grant of 499 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.

	/s/ Kenneth M. Dodgen, Attorney-in-Fact	07/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many PRIM shares did Director Carla Mashinski receive?

She received 499 restricted shares on 07/30/2025.

What is the value of the PRIM stock grant disclosed in the Form 4?

The grant is valued at $37,500, based on the average June 2025 closing price.

Does the filing indicate any sale of PRIM shares?

No. The transaction was an acquisition for compensation; no shares were sold or disposed.

What is Carla Mashinski’s total beneficial ownership after the transaction?

She now directly owns 23,310 PRIM shares.

Are the newly granted PRIM shares immediately tradeable?

No. The restricted shares cannot be sold for 12 months from the grant date.

Is this Form 4 filing considered material to PRIM’s financial outlook?

It is generally viewed as routine and immaterial to the company’s financial performance.